Skip to main content

The Use of Maternal Plasma for Prenatal RhD Blood Group Genotyping

  • Protocol
DNA and RNA Profiling in Human Blood

Part of the book series: METHODS IN MOLECULAR BIOLOGY™ ((MIMB,volume 496))

Abstract

Alloimmunization to the blood group antibody anti-RhD (anti-D) is the most common cause of hemolytic disease of the fetus and newborn. Knowledge of fetal D type in women with anti-D makes management of the pregnancy much easier and avoids unnecessary procedures in those women with a D-negative fetus. Fetal D typing can be performed by detection of an RHD gene in cell-free DNA in the plasma of D-negative pregnant women. The technology involves real-time quantitative polymerase chain reactions targeting exons 4, 5, and 10 of RHD, with the exons 4 and 10 tests performed as a multiplex. Testing for SRY in multiplex with the RHD exon 5 test provides an internal control for the presence of fetal DNA when the fetus is male. Fetal D typing has become the standard of care in England in pregnant women with a significant level of anti-D.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 119.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 159.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Klein, H. G., Anstee, D. J. (2005) Blood Transfusion in Clinical Medicine, 11th edition. Blackwell Publishing, Oxford, UK.

    Google Scholar 

  2. National Institute for Clinical Excellence (2002) Technology Appraisal Guidance 41. Guidance on the Use of Routine Antenatal Anti-D Prophylaxis for RhD-Negative Women. NICE, London, UK.

    Google Scholar 

  3. van der Schoot, C. E., Tax, G. H. M., Rijnders, R. J. P., de Haas, M., Christiaens, G. C. M. L. (2003) Prenatal typing of Rh and Kell blood group system antigens: the edge of a watershed. Transfus Med Rev 17, 31–44.

    Article  PubMed  Google Scholar 

  4. Daniels, G., Finning, K., Martin, P., Soothill, P. (2004) Fetal blood group genotyping from DNA from maternal plasma: an important advance in the management and prevention of haemolytic disease of the fetus and newborn. Vox Sang 87, 225–232.

    Article  CAS  PubMed  Google Scholar 

  5. Daniels, G., Finning, K., Martin, P., Summers, J. (2006) Fetal blood group genotyping. Present and future. Ann NY Acad Sci 1075, 88–95.

    Article  CAS  PubMed  Google Scholar 

  6. Lo, Y. M., Tein, M. S. C., Lau, T. K., Haines, C. J., Leung, T. N., Poon, P. M. K., et al. (1998) Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis. Am J Hum Genet 62, 768–775.

    Article  CAS  PubMed  Google Scholar 

  7. Finning, K. M., Martin, P. G., Soothill, P. W., Avent, N. D. (2002) Prediction of fetal D status from maternal plasma: introduction of a new noninvasive fetal RHD genotyping service. Transfusion 42, 1079–1085.

    Article  CAS  PubMed  Google Scholar 

  8. Finning, K., Martin, P., Summers, J., Daniels, G. (2007) Fetal genotyping for the K (Kell) and Rh C, c, and E blood groups on cell-free fetal DNA from maternal plasma. Transfusion 47, 2126–2133.

    Article  CAS  PubMed  Google Scholar 

  9. Daniels, G. (2002) Human Blood Groups, 2nd edition. Oxford: Blackwell Science.

    Google Scholar 

  10. Colin, Y., Chérif-Zahar, B., Le Van Kim, C., Raynal, V., Van Huffel, V., Cartron, J-P. (1991) Genetic basis of the RhD-positive and RhD-negative blood group polymorphism as determined by Southern analysis. Blood 78, 2747–2752.

    Google Scholar 

  11. Singleton, B. K., Green, C. A., Avent, N. D., Martin, P. G., Smart, E., Daka, A., et al. (2000) The presence of an RHD pseudogene containing a 37 base pair duplication and a nonsense mutation in most Africans with the Rh D-negative blood group phenotype. Blood 95, 12–18.

    CAS  PubMed  Google Scholar 

  12. Faas, B. H. W., Beckers, E. A. M., Wildoer, P., Ligthart, P. C., Overbeeke, M. A., Zondervan, H. A., et al. (1997) Molecular background of VS and weak C expression in blacks. Transfusion 37, 38–44.

    Article  CAS  PubMed  Google Scholar 

  13. Page-Christiaens, G. C., Bossers, B., van der Schoot, C. E., De Haas, M. (2006) Use of bi-allelic insertion/deletion polymorphisms as a positive control for fetal genotyping in maternal blood: first clinical experience. Ann NY Acad Sci 1075, 123–129.

    Article  CAS  PubMed  Google Scholar 

  14. Chan, K. C., Ding, C., Gerovassili, A., Yeung, S. W., Chiu, R. W., Leung, T. N., et al. (2006) Hypermethylated RASSF1A in maternal plasma: A universal fetal DNA marker that improves the reliability of noninvasive prenatal diagnosis. Clin Chem 52, 2211–2218.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Humana Press, a part of Springer Science+Business Media, LLC

About this protocol

Cite this protocol

Finning, K., Martin, P., Daniels, G. (2009). The Use of Maternal Plasma for Prenatal RhD Blood Group Genotyping. In: Bugert, P. (eds) DNA and RNA Profiling in Human Blood. METHODS IN MOLECULAR BIOLOGY™, vol 496. Humana Press. https://doi.org/10.1007/978-1-59745-553-4_11

Download citation

  • DOI: https://doi.org/10.1007/978-1-59745-553-4_11

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-934115-93-0

  • Online ISBN: 978-1-59745-553-4

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics